1pwq: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /><applet load="1pwq" size="450" color="white" frame="true" align="right" spinBox="true" caption="1pwq, resolution 3.52Å" /> '''Crystal structure of...
 
No edit summary
Line 1: Line 1:
[[Image:1pwq.jpg|left|200px]]<br /><applet load="1pwq" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1pwq.jpg|left|200px]]<br /><applet load="1pwq" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1pwq, resolution 3.52&Aring;" />
caption="1pwq, resolution 3.52&Aring;" />
'''Crystal structure of Anthrax Lethal Factor complexed with Thioacetyl-Tyr-Pro-Met-Amide, a metal-chelating peptidyl small molecule inhibitor'''<br />
'''Crystal structure of Anthrax Lethal Factor complexed with Thioacetyl-Tyr-Pro-Met-Amide, a metal-chelating peptidyl small molecule inhibitor'''<br />


==Overview==
==Overview==
Recent events have created an urgent need for new therapeutic strategies, to treat anthrax. We have applied a mixture-based peptide library approach, to rapidly determine the optimal peptide substrate for the anthrax lethal, factor (LF), a metalloproteinase with an important role in the, pathogenesis of the disease. Using this approach we have identified, peptide analogs that inhibit the enzyme in vitro and that protect cultured, macrophages from LF-mediated cytolysis. The crystal structures of LF bound, to an optimized peptide substrate and to peptide-based inhibitors provide, a rationale for the observed selectivity and may be exploited in the, design of future generations of LF inhibitors.
Recent events have created an urgent need for new therapeutic strategies to treat anthrax. We have applied a mixture-based peptide library approach to rapidly determine the optimal peptide substrate for the anthrax lethal factor (LF), a metalloproteinase with an important role in the pathogenesis of the disease. Using this approach we have identified peptide analogs that inhibit the enzyme in vitro and that protect cultured macrophages from LF-mediated cytolysis. The crystal structures of LF bound to an optimized peptide substrate and to peptide-based inhibitors provide a rationale for the observed selectivity and may be exploited in the design of future generations of LF inhibitors.


==About this Structure==
==About this Structure==
1PWQ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bacillus_anthracis Bacillus anthracis] with ZN and SD2 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Anthrax_lethal_factor_endopeptidase Anthrax lethal factor endopeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.83 3.4.24.83] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1PWQ OCA].  
1PWQ is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Bacillus_anthracis Bacillus anthracis] with <scene name='pdbligand=ZN:'>ZN</scene> and <scene name='pdbligand=SD2:'>SD2</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Anthrax_lethal_factor_endopeptidase Anthrax lethal factor endopeptidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.24.83 3.4.24.83] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1PWQ OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Bacillus anthracis]]
[[Category: Bacillus anthracis]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Liddington, R.C.]]
[[Category: Liddington, R C.]]
[[Category: Schwarzenbacher, R.]]
[[Category: Schwarzenbacher, R.]]
[[Category: Wong, T.Y.]]
[[Category: Wong, T Y.]]
[[Category: SD2]]
[[Category: SD2]]
[[Category: ZN]]
[[Category: ZN]]
Line 24: Line 24:
[[Category: small molecule peptidic inhibitor]]
[[Category: small molecule peptidic inhibitor]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 00:11:24 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:33:18 2008''

Revision as of 15:33, 21 February 2008

File:1pwq.jpg


1pwq, resolution 3.52Å

Drag the structure with the mouse to rotate

Crystal structure of Anthrax Lethal Factor complexed with Thioacetyl-Tyr-Pro-Met-Amide, a metal-chelating peptidyl small molecule inhibitor

OverviewOverview

Recent events have created an urgent need for new therapeutic strategies to treat anthrax. We have applied a mixture-based peptide library approach to rapidly determine the optimal peptide substrate for the anthrax lethal factor (LF), a metalloproteinase with an important role in the pathogenesis of the disease. Using this approach we have identified peptide analogs that inhibit the enzyme in vitro and that protect cultured macrophages from LF-mediated cytolysis. The crystal structures of LF bound to an optimized peptide substrate and to peptide-based inhibitors provide a rationale for the observed selectivity and may be exploited in the design of future generations of LF inhibitors.

About this StructureAbout this Structure

1PWQ is a Single protein structure of sequence from Bacillus anthracis with and as ligands. Active as Anthrax lethal factor endopeptidase, with EC number 3.4.24.83 Full crystallographic information is available from OCA.

ReferenceReference

The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor., Turk BE, Wong TY, Schwarzenbacher R, Jarrell ET, Leppla SH, Collier RJ, Liddington RC, Cantley LC, Nat Struct Mol Biol. 2004 Jan;11(1):60-6. Epub 2003 Dec 29. PMID:14718924

Page seeded by OCA on Thu Feb 21 14:33:18 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA